Hanne Capital
Shanghai, Shanghaihannecapital.com
Overview
Hanne Capital is a venture capital firm founded in 2017. It specializes in investing in the biotech, pharma, and medtech sectors, with a focus on growth opportunities in Greater China. The firm primarily invests in Series A rounds in China-based startups across Life Sciences, High Tech, and Healthcare.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Kyinno Bio | Apr 2021 | Series A | Co-investor |
| BioNova Pharmaceuticals (Shanghai) Ltd. | Nov 2020 | Series B Extension | Co-investor |
| Rezubio Pharmaceuticals Co., Ltd. | Sep 2019 | Angel | Co-investor |
| HiFiBiO Therapeutics | Aug 2019 | Series C | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
